Walleye Trading’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,808
Closed -$334K 4520
2025
Q4
$334K Buy
+25,808
New +$331K ﹤0.01% 3081
2025
Q1
Sell
-12,128
Closed -$361K 4523
2024
Q4
$361K Buy
+12,128
New +$257K ﹤0.01% 2852
2024
Q1
Sell
-2,094
Closed -$31.3K 5151
2023
Q4
$31.3K Buy
+2,094
New +$28K ﹤0.01% 4434
2023
Q2
Sell
-25,992
Closed -$1.56M 5035
2023
Q1
$1.56M Buy
+25,992
New +$2.08M ﹤0.01% 1854
2022
Q1
Sell
-11,086
Closed -$817K 5727
2021
Q4
$832K Buy
11,086
+237
+2% +$23.8K ﹤0.01% 2416
2021
Q3
$1.26M Buy
10,849
+1,645
+18% +$249K ﹤0.01% 1985
2021
Q2
$2.04M Buy
9,204
+5,537
+151% +$1.08M 0.01% 1477
2021
Q1
$485K Buy
+3,667
New +$580K ﹤0.01% 2684
2020
Q3
Sell
-4,423
Closed -$354K 4463
2020
Q2
$262K Buy
4,423
+2,020
+84% +$133K ﹤0.01% 2873
2020
Q1
$162K Sell
2,403
-3,356
-58% -$265K ﹤0.01% 2784
2019
Q4
$485K Sell
5,759
-9,894
-63% -$799K ﹤0.01% 2433
2019
Q3
$1.17M Sell
15,653
-5,036
-24% -$403K 0.01% 1480
2019
Q2
$1.31M Buy
+20,689
New +$1.05M 0.01% 1383
2019
Q1
Sell
-12,193
Closed -$587K 4592
2018
Q4
$408K Buy
+12,193
New +$446K ﹤0.01% 2681

Other funds holding NVCR

Walleye Trading's NVCR Position: Q1 2026 in Review

Walleye Trading sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 25,808 shares — an estimated $334K sold.

Walleye Trading first reported a position in NVCR in Q4 2018 and held it in 14 quarters. The position peaked at $2.04M in Q2 2021. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Walleye Trading reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 25,808 NovoCure shares in Q1 2026, an estimated $334K.
  • Walleye Trading first reported a position in NovoCure in Q4 2018 and held it in 14 quarters.
  • Walleye Trading's NovoCure position peaked at $2.04M in Q2 2021.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.